California Stem Cell Raises Series B

Irvine-based California Stem Cell, a manufacturer of human stem cells, said today that it has raised a Series B round of funding. Amount of funding, and the investors, was not disclosed by the company. The firm said the new funding will go to support the advancement of its products toward human clinical trials, plus towards generation and distribution of its tools. California Stem Cell is developing stem cell products for both research, as well as a product for treating Spinal Muscular Atrophy (SMA).